MHJ-627 successfully inhibited the kinase activity of ERK5 (IC<sub>50</sub>: 0.91 μM) and promoted the mRNA expression of tumor suppressors and anti-metastatic genes. The gene discussed is MAPK7; the disease is neoplasm.